Epididymis cancer is a very rare cancer that starts in the coiled tube behind the testicle that stores sperm. Early symptoms of epididymis cancer can include a lump, swelling, heaviness, or aching in the scrotum, but some people have few symptoms at first. It is usually found in adults, and treatment often involves surgery with other care such as radiation therapy or chemotherapy in some cases. Not everyone will have the same experience. The outlook for epididymis cancer depends on the type and stage, and earlier diagnosis is generally linked with a better chance of successful treatment.
How many people live with Epididymis cancer?
Epididymis cancer is so rare that no recent, widely accepted estimate says how many people are living with it worldwide. The same is true in the United States, where a standard national count is also not consistently reported because most published information comes from individual case reports and very small case series rather than population-wide tracking.
Overview
Epididymis cancerSymptoms
Epididymis cancer may cause a painless lump or swelling near the testicle, a feeling of heaviness, or dull groin pain. Early symptoms of epididymis cancer can be easy to miss, and some people notice no symptoms at first.
Outlook and prognosis
The outlook for epididymis cancer is often good, especially when it is found early and treated before it spreads. Prognosis depends on the tumor type, stage, and whether surgery removes it fully. Many people with epididymis cancer do well with follow-up care.
Causes and risk factors
Epididymis cancer is very rare, and the exact cause is often unknown. It likely develops from DNA changes that build up over time. No clear lifestyle risks are proven, but older age and prior radiation to the area may raise risk.
Genetic influences
Genetics are not thought to play a major role in most epididymis cancer cases. Genetic variations may affect how some tumors develop, but inherited risk for epididymis cancer appears rare and is not well defined.
Diagnosis
Epididymis cancer is diagnosed with a physical exam, scrotal ultrasound, and imaging tests. Doctors usually confirm the diagnosis with a biopsy after reviewing symptoms and scan results.
Treatment and drugs
Treatment for epididymis cancer usually starts with surgery to remove the tumor, and sometimes the testicle too. Depending on the type and stage, radiation or chemotherapy may follow. Follow-up scans and exams help watch for recurrence.
Symptoms
Epididymis cancer often shows up as a new lump or swelling beside the testicle rather than a dramatic illness. Symptoms vary from person to person and can change over time. The early symptoms of epididymis cancer can be easy to miss because they may cause little or no pain.
A small, firm lump near the back or upper part of a testicle is a common sign. It may seem separate from the testicle itself, but by touch alone it can be hard to tell exactly where it starts.
The scrotum may look larger on one side or feel unusually full. Some people first notice this while getting dressed, showering, or crossing their legs.
Some people have a dull ache or tenderness in the scrotum, groin, or lower belly. Pain is not always present, so a painless mass can still be important.
The scrotum can start to feel heavy, tight, or as if something is pulling downward. This can become more noticeable when walking, exercising, or standing for a long time.
How people usually first notice Epididymis cancer?
Epididymis cancer is often first noticed as a small lump, swelling, or a feeling of heaviness near the testicle, sometimes found by chance while washing, dressing, or doing a self-check. Some people with epididymis cancer also notice a dull ache in the scrotum, groin, lower belly, or back, although early on it may cause little or no pain. Because these changes can also happen with more common and less serious problems, such as cysts or infections, a new lump or ongoing swelling is still worth getting checked promptly.
Types of Epididymis cancer
Epididymis cancer is very rare, so there is no simple day-to-day symptom typing system the way there is for some other conditions. Instead, doctors usually talk about types of epididymis cancer based on where the cancer started, and symptoms can overlap a lot between them. Sometimes, symptoms cluster together in recognizable ways. Many people first notice a small lump, swelling, or a feeling of heaviness in the scrotum, while pain may be mild or absent.
Primary cancer
This starts in the epididymis itself, the small coiled tube behind the testicle. It often shows up as a slow-growing, usually painless lump or swelling, and some may find it is first noticed while washing or getting dressed. Because it is rare, the exact symptoms can vary depending on the tumor cell type.
Secondary cancer
This means cancer spread to the epididymis from somewhere else nearby or from another part of the body. In addition to a lump or swelling in the scrotum, people may also have symptoms linked to the original cancer, such as ongoing pelvic discomfort, urinary changes, or symptoms from another organ. Secondary tumors may be more likely to appear along with other signs of advanced disease rather than as the only problem.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms from epididymis cancer, a very rare cancer in the small tube behind the testicle. Unlike some more common cancers, there are no well-established screening tests or preventive medicines for people without symptoms, although getting any new lump, swelling, heaviness, or pain in the scrotum checked promptly may help it be found earlier rather than prevent it. That may not change when symptoms begin, but noticing changes early and seeking care quickly is still a sensible, worthwhile step.
What genetics can tell you about symptoms
For epididymis cancer, genetics usually cannot tell doctors much about which symptoms you will have, how severe they will be, or exactly when they will start. Because this cancer is very rare, there is no well-established pattern linking specific gene changes to day-to-day symptoms; in most cases, symptoms depend more on where the tumor is, how large it is, and whether it has spread. If genetic testing is considered, it is usually to look for inherited cancer risk in the broader picture, not to predict the symptom pattern of epididymis cancer itself.
Causes and risk factors
Because epididymis cancer is very rare, the exact risk factors for epididymis cancer are not well defined. Many living with epididymis cancer have no clear cause, but risk may rise with older age or long-term inflammation in the scrotum. Some cancers found in the epididymis start elsewhere, and a small number may be tied to inherited gene changes. Researchers are still learning how these pieces fit together. No lifestyle habit has been proven to directly cause epididymis cancer, and links with radiation, workplace chemicals, or other environmental exposures remain uncertain.
What are the most common causes or risk factors?
There is no single known cause of epididymis cancer, and because it is so rare, doctors have not found clear, well-proven risk factors the way they have for some other cancers. The strongest pattern seen is age, since many adult cases are found in middle-aged or older men, although some types can happen in boys and younger adults. No common inherited gene change or lifestyle factor has been clearly shown to cause most cases.
Environmental and biological risk factors
Epididymis cancer is so uncommon that doctors have not identified a clear set of proven causes. Most information comes from small case reports, so the known risk factors for epididymis cancer are less certain than they are for more common cancers. Researchers are still exploring how outside influences interact with our inner biology.
Many reported cases happen in adults, especially middle-aged or older adults. Age does not directly cause cancer, but risk can rise over time as cells build up damage.
Long-term inflammation or repeated infection in the epididymis or nearby tissues may increase ongoing cell stress. This is considered a possible biological risk, although the evidence is limited because epididymis cancer is very rare.
Previous radiation to the pelvis or genital area can raise the risk of some cancers in nearby tissues. For epididymis cancer, this link is possible but has not been firmly proven.
Long-term exposure to certain workplace chemicals or pollutants has been studied in cancers of the male reproductive system. No single exposure has been clearly shown to cause epididymis cancer, but environmental exposure remains an area doctors continue to study.
Genetic risk factors
Because epididymis cancer is extremely rare, its inherited causes are not well mapped. Most cases do not have a clearly proven family-linked genetic cause. Carrying a genetic change doesn’t guarantee the condition will appear. The main inherited link is a rare condition called von Hippel-Lindau syndrome, but this is tied more strongly to benign epididymal tumors than to most true epididymis cancers.
No proven gene: No single inherited gene change has been shown to cause most cases of epididymis cancer. Because this cancer is so uncommon, studies are small and the genetic picture is still incomplete.
VHL syndrome: A rare inherited condition called von Hippel-Lindau syndrome can cause papillary growths in the epididymis. These growths are usually benign, so this syndrome is not a common explanation for true epididymis cancer.
Family history: A family history of von Hippel-Lindau syndrome or the tumors seen with it may prompt a genetics referral. Even when early symptoms of epididymis cancer lead to testing, symptoms alone cannot show whether an inherited change is present.
Tumor DNA changes: Like other cancers, epididymis cancer is thought to arise after DNA changes build up inside cells. In most cases, these changes are acquired in the tumor itself rather than passed down through a family.
Lifestyle risk factors
Epididymis cancer is extremely rare, so its specific lifestyle risk factors are not well defined. Current research has not confirmed any major diet, exercise, alcohol, or smoking pattern as a clear cause of this tumor. When people ask about lifestyle risk factors for epididymis cancer, the most accurate answer is that evidence is limited and mostly indirect. Still, some habits may affect overall cancer health, symptom recognition, and treatment outcomes.
Smoking has not been proven to specifically cause epididymis cancer. However, avoiding tobacco supports blood flow, tissue healing, and overall cancer health if treatment such as surgery is needed.
Excess body weight is not an established direct risk factor for epididymis cancer. Even so, maintaining a healthy weight may help reduce chronic inflammation and lower the risk of treatment complications.
Low physical activity has not been clearly linked to developing epididymis cancer. Regular exercise can still support metabolic health, recovery, and energy levels during and after treatment.
No specific food or dietary pattern has been shown to directly raise the risk of epididymis cancer. A balanced diet may still help support immune function, general health, and resilience during cancer care.
Risk prevention
Because epididymis cancer is very rare, there is no proven way to prevent it completely. In most people, the exact cause is not clear, so prevention focuses on lowering general cancer risk and getting any scrotal changes checked early. Prevention is about lowering risk, not eliminating it completely. Many living with concerns about epididymis cancer benefit most from noticing new symptoms early and keeping up with routine medical care.
Not smoking helps lower the risk of many cancers and supports overall tissue health. While no specific link clearly proves smoking causes epididymis cancer, avoiding tobacco is a sensible way to reduce cancer risk overall.
If you work around industrial chemicals, solvents, or heavy dust, use recommended protective equipment and follow workplace safety rules. This may help reduce unnecessary exposure to substances that can raise cancer risk in general.
Regular exercise, a balanced diet, and maintaining a healthy weight support the immune system and long-term health. These steps have not been shown to specifically prevent epididymis cancer, but they can lower the risk of several other cancers and chronic illnesses.
A new lump, swelling, heaviness, or ongoing pain in the scrotum should be checked by a doctor without delay. Early attention to possible early symptoms of epididymis cancer can help rule out more common causes and may lead to faster treatment if cancer is present.
Can you prevent Epididymis cancer?
There is no known way to reliably prevent epididymis cancer, which is a very rare cancer in the small tube behind the testicle that stores sperm. Because it is so uncommon and its causes are not well understood, no specific lifestyle change has been proven to stop it from happening.
Transmission
Epididymis cancer is not infectious, so it cannot be passed from one person to another through sex, kissing, touch, sharing toilets, or being around someone who has it. For many people, this is the most important point: even though the cancer can spread to other parts of the same body, it does not spread between people.
Most epididymis cancer is also not something families pass down in a clear way, so when people ask about how epididymis cancer is inherited, the answer is usually that it is not inherited in the way many genetic conditions are. Because this cancer is very rare, doctors usually look at it as an individual medical problem rather than a contagious illness.
When to test your genes
There is no routine genetic test recommended for early detection of epididymis cancer because this cancer is very rare and most cases are not tied to a known inherited risk. Genetic testing may be worth discussing if you were diagnosed at a young age, have a strong family history of related cancers, or have features suggesting an inherited cancer syndrome.
Diagnosis
Epididymis cancer is very rare, so the first clues are often a lump, swelling, heaviness, or ongoing discomfort in the scrotum that leads to a medical visit. Doctors usually begin with an exam and an ultrasound, then use more tests to see whether the mass looks harmless or suspicious. Because many scrotal lumps are not cancer, the diagnosis of epididymis cancer often takes a few steps to rule out more common causes.
A doctor asks about when the lump or swelling started, whether it is painful, and if there have been infections, injuries, or prior surgeries in the area. A detailed family and health history can help put the findings in context and rule out more common causes of scrotal symptoms.
The scrotum, testicles, and groin are checked for a mass, tenderness, firmness, or enlarged lymph nodes. This helps doctors estimate whether the lump may be coming from the epididymis, the testicle itself, or nearby tissues.
This is usually the first imaging test because it can show the size, shape, and exact location of a scrotal mass. Ultrasound can often tell whether a lump is fluid-filled or solid, which helps guide how epididymis cancer is diagnosed.
Blood work may be done to look for signs of infection or inflammation and to check general health before any procedure. Tumor marker tests may also help rule out more common testicular cancers, although they are not specific for epididymis cancer.
How is Epididymis cancer diagnosed?
Doctors usually start with a physical exam and an ultrasound, which can show whether a lump or swelling is coming from the epididymis, the small tube behind the testicle, rather than the testicle itself. If cancer is suspected, scans such as a CT scan may be used to check nearby areas and see if it has spread, and blood tests may help rule out more common testicular cancers. The diagnosis is usually confirmed only after the growth is removed or a tissue sample is examined under a microscope, and genetic testing is not a routine part of diagnosis for most people.
Stages of Epididymis cancer
Epididymis cancer is usually described in stages based on how far the tumor has grown and whether it has spread. Because this cancer is very rare, doctors often stage it using the same basic approach used for other nearby cancers: looking at the tumor itself, nearby lymph nodes, and any spread to distant parts of the body. Step by step, they look for the most likely explanations, especially when early symptoms of epididymis cancer such as a small lump, swelling, or a feeling of heaviness can overlap with more common noncancerous conditions.
Stage 1
The cancer is limited to the epididymis or very close nearby tissue. It has not spread to lymph nodes or distant organs.
Stage 2
The tumor has grown further into nearby structures in the scrotum, spermatic cord, or surrounding tissue. It still has no clear spread to distant parts of the body.
Stage 3
Epididymis cancer has spread to nearby lymph nodes, often in the pelvis or back of the abdomen. People may still have local symptoms, but the stage is higher because cancer cells have moved beyond the original area.
Stage 4
The cancer has spread to distant organs such as the lungs, liver, or bones. At this stage, symptoms can come from both the original tumor and the areas where it has spread.
Outlook and prognosis
Because epididymis cancer is extremely rare, prognosis is based mostly on small case reports and depends heavily on the tumor type, stage, and whether it can be completely removed with surgery. In general, people with localized disease that is fully excised can have a favorable outlook, while cancers that have spread to nearby tissues, lymph nodes, or distant organs carry a much poorer prognosis. Some epididymal malignancies behave relatively slowly, but others, especially aggressive sarcomas or metastatic tumors involving the epididymis, can progress quickly. Mortality data are limited because so few cases are reported, but deaths are more likely in advanced or recurrent disease than in cancers found early and treated definitively. Close follow-up is important, since recurrence risk varies by pathology and may affect long-term survival.
Long-term effects
For many, the long-term effects of epididymis cancer depend on how early it was found, whether it spread, and which treatments were needed. Many living with epididymis cancer recover well after treatment, but some may have lasting changes in the scrotum, fertility, or comfort with daily movement. Long-term effects vary widely, especially because this cancer is rare and treatment plans can differ from one person to another. Some effects come from the cancer itself, while others are linked to surgery, radiation, or other treatment.
Some people have lasting swelling, firmness, or a different feel in the scrotum after epididymis cancer treatment. This can make exercise, sex, or even sitting for long periods less comfortable.
Ongoing aching, tenderness, or nerve-related pain in the groin or scrotum can happen after surgery or from scar tissue. For many, symptoms are mild, but some may find that lifting, walking, or tight clothing brings the discomfort back.
If treatment affects the epididymis, testicle, or nearby structures, fertility can be reduced. This may matter later for people hoping to have children, even if the early symptoms of epididymis cancer seemed limited to a small lump or swelling.
If one testicle is removed, the remaining testicle often makes enough testosterone for the body’s needs. In some cases, though, energy, sex drive, or mood can be affected, especially if there were already problems with testicular function.
How is it to live with Epididymis cancer?
Living with epididymis cancer can feel unsettling because it affects an intimate part of the body and often brings worry not just about pain or treatment, but also about fertility, sexual health, and what comes next. Day to day, many people living with epididymis cancer may need scans, appointments, surgery, or recovery time that can interrupt work, exercise, and intimacy, although the exact impact depends on the tumor, its stage, and the treatment used. It often reaches beyond the individual as well, because partners, family, and close friends may take on emotional strain, caregiving tasks, and practical responsibilities, yet clear information and support can help everyone feel more steady and less alone.
Treatment and drugs
Treatment for epididymis cancer depends on the size of the tumor, whether it has spread, and your overall health, but surgery is usually the main treatment. Doctors often remove the tumor and sometimes the affected testicle and nearby tissues to lower the chance that cancer is left behind. If epididymis cancer has spread or looks higher risk under the microscope, treatment plans often combine several approaches, such as radiation therapy, chemotherapy, or in some cases close follow-up with regular scans and exams. Not every treatment works the same way for every person, so your care team may tailor treatment to the exact type of tumor and how far it has grown.
Can you cure Epididymis cancer?
Sometimes, yes—if epididymis cancer is found early and has not spread, surgery may remove it completely and some people are cured. If it has spread or comes back, a full cure may not be possible, but treatment such as surgery and sometimes radiation or drug treatment can help control the cancer, ease symptoms, and help people live longer.
Non-drug treatment
Treatment for epididymis cancer often centers on removing the tumor and checking whether it has spread, because this cancer is very rare and care is usually tailored to the individual. Some may find that treatment affects day-to-day concerns such as pain, swelling, fertility, sexual comfort, and time away from work. Beyond prescriptions, supportive therapies can help with recovery, strength, and coping during and after treatment. Because there is no single standard plan for every case, treatment options for epididymis cancer may differ based on tumor type, size, and stage.
Surgery is usually the main non-drug treatment for epididymis cancer. It may involve removing the epididymis, the testicle, or nearby tissue if needed to fully remove the cancer.
If scans or exam findings suggest spread, surgeons may remove nearby lymph nodes to check for cancer. This can help stage the disease more accurately and guide the next steps in care.
Radiation uses carefully aimed high-energy beams to destroy cancer cells in a specific area. It may be used after surgery or, less often, when surgery is not the best option.
In selected situations, close follow-up may be reasonable after treatment, especially if the tumor appears localized and fully removed. Not every approach works the same way, so visits may include exams, scans, and sometimes blood tests to watch for signs that the cancer has returned.
Your genes may have an impact on how drugs work for you
For people with epididymis cancer, treatment is often centered on surgery, so there is less known about how inherited gene differences change the way cancer medicines work than there is for some other cancers. If drug treatment is needed, small differences in the body’s genes can sometimes affect how quickly a medicine is broken down or how strongly side effects are felt, which may help explain why one person does well while another has more trouble. Still, there is no routine gene-based drug matching that is widely used for this rare cancer, so doctors usually choose treatment based more on the tumor type, its stage, and your overall health.
Pharmacological treatments
Drug treatment is not the main approach for epididymis cancer, because this cancer is very rare and surgery is usually the first treatment. When medicines are used, they are most often part of treatment for advanced epididymis cancer, cancer that has spread, or cancer that has come back after surgery. The exact drugs depend a lot on the tumor type found under the microscope. Not everyone responds to the same medication in the same way.
There is no single standard medicine used for all epididymis cancer. Doctors choose drug treatment based on the exact cell type, how far the cancer has spread, and whether surgery has already been done.
Cisplatin is one of the main chemotherapy drugs that may be used when epididymis cancer is treated like other aggressive tumors in the testicular area. It is usually given with other drugs rather than on its own.
Bleomycin, etoposide, and cisplatin are sometimes used together in a combination called BEP. This may be considered if the cancer behaves more like a germ cell tumor than a typical epididymal tumor.
If the tumor is a sarcoma arising near the epididymis, doctors may use drugs such as doxorubicin and ifosfamide. These medicines are more often used when the cancer is advanced, recurrent, or cannot be fully removed.
Genetic influences
Because epididymis cancer is so rare, doctors do not have strong evidence that it usually runs in families. Most cases seem to happen sporadically, which means the DNA changes likely develop in the tumor over time rather than being inherited at birth. It’s natural to ask whether family history plays a role. At this point, no single inherited gene has been shown to explain most epididymis cancer, although genetics may be looked at more closely if it appears at a younger age or if several relatives have had rare cancers. For many people with epididymis cancer, this means genetic testing is not routine, but it may be considered when the personal or family history suggests a broader inherited cancer syndrome. If you are concerned about whether epididymis cancer runs in families, your care team can help you decide whether a genetics referral would be useful.
Is Epididymis cancer genetic?
Genetics are not thought to play a major role in most epididymis cancer cases. Genetic variations may affect how some tumors develop, but inherited risk for epididymis cancer appears rare and is not well defined.
Having a genetic risk is not necessarily a diagnosis
Changes in genes, often called genetic variants, are a usual part of being human and are found throughout the general population. Most of these variants do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and outside factors play a role. Still, there are situations in which one well-studied variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Because epididymis cancer is so rare, treatment is usually chosen based on the exact cell type, how far the cancer has spread, and whether surgery can remove it, rather than on a routine gene test. If you are wondering how genetics affect treatment for epididymis cancer, the role is often smaller than it is for some more common cancers. Not every difference in response is genetic, but inherited gene differences can sometimes affect how the body handles certain cancer medicines and how likely side effects are, so your care team may look closely at your medical and family history. In advanced or recurrent epididymis cancer, doctors may sometimes test the tumor itself to look for changes that could open the door to a targeted drug or a clinical trial, although this is not standard for everyone. For many living with epididymis cancer, this means genetics may help fine-tune treatment in selected cases, but they do not usually replace the basic decisions guided by the pathology report and stage of the disease. If treatment beyond surgery is being considered, it is reasonable to ask whether tumor or inherited genetic testing is likely to change your options.
Interactions with other conditions
A lump, heaviness, or swelling in the scrotum can easily disrupt everyday life, and with epididymis cancer these changes can look a lot like other, more common problems at first. The early symptoms of epididymis cancer may overlap with epididymitis, a painful infection or inflammation, as well as fluid-filled swelling, cysts, hernias, or testicular cancer, so doctors usually need an exam and imaging to sort out the cause. Certain diseases may overlap, meaning one condition can resemble another even when the treatment is very different. If someone already has a scrotal infection or long-standing swelling, it may take longer to recognize that a tumor is also present. Epididymis cancer can also affect overall treatment planning if you are living with other illnesses, since surgery, scans, and medicines may need to be adjusted for problems such as heart disease, kidney disease, or bleeding disorders. Because this cancer is rare, care is often most helpful when urology, cancer, and primary care teams work together to rule out related conditions and choose the safest next steps.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Epididymis cancer?
A lump, swelling, or aching in this area can also be caused by a harmless cyst, an infection of the tube behind the testicle or the testicle itself, a fluid buildup around the testicle, or a groin hernia. Testicular cancer can sometimes feel similar too, so any new lump, swelling, or ongoing pain in the scrotum should be checked by a doctor.
History
A small lump near the testicle, a feeling of heaviness in the scrotum, or swelling that does not go away has long been the kind of change that sends people to a doctor. In the past, these symptoms were often hard to sort out because many scrotal conditions can look similar at first, including infections, cysts, and tumors arising from nearby tissues. That made the history of epididymis cancer less straightforward than the history of some better-known cancers.
As doctors began to examine removed tissue under the microscope in the 1800s and early 1900s, they became better at telling apart cancers of the testicle, spermatic cord, and epididymis. Once considered rare, now recognized as extremely uncommon, epididymis cancer has remained a diagnosis most doctors see rarely, if ever, in routine practice. Early reports were often single case descriptions, which meant knowledge grew slowly and was based on small numbers rather than large studies.
Over time, improvements in pathology helped doctors identify different tumor types that can affect the epididymis. Imaging tests, especially ultrasound, later made it easier to see whether a lump seemed to be inside the testicle or in structures next to it, which matters because treatment and outlook can differ. For many living with epididymis cancer, this shift has meant a more accurate diagnosis and less confusion early in the workup.
Modern care has built on those careful early observations. Surgeons, pathologists, and cancer specialists now use a combination of physical exam, imaging, and tissue analysis to confirm epididymis cancer and to rule out more common causes of a scrotal mass. Researchers have also learned that some tumors found in the epididymis started somewhere else in the body and spread there, while others begin in the epididymis itself.
Because epididymis cancer is so rare, much of what is known still comes from case reports and small case series rather than large clinical trials. Even so, today’s understanding is far clearer than it was in the past. If you are reading about the early symptoms of epididymis cancer, it helps to know that awareness and diagnostic tools have improved a great deal, even though the condition remains uncommon.